Journals / Anadolu Kardiyoloji Dergisi / 2010 / Cilt: 10 - Sayı: 1

Oral anticoagulation in atrial fibrillation: Are the problems solved? (Editorial Comment )

Atriyal fibrilasyonda oral antikoagülan tedavi: Sorunlar çözüldü mü? (Editöryel Yorum)

Pages
41–42
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

DOĞAN, U. (2022). Oral anticoagulation in atrial fibrillation: Are the problems solved? (Editorial Comment ). Anadolu Kardiyoloji Dergisi, Cilt: 10 - Sayı: 1, 41–42. https://ajindex.com/articles/437512

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol 2009
  2. doi:10.1016/j.amjcard.2009.07.022 PMid:19932788 2. Pisters R, de Vos CB, Nieuwlaat R, Crijns HJ. Use and underuse of oral anticoagulation for stroke prevention in atrial fibrillation: old and new paradigms. Semin Thromb Hemost 2009
  3. doi:10.1055/s-0029-1241048 PMid:19787559 3. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007
  4. PMid:17577005 4. Waldo AL, Becker RC, Tapson VF, Colgan KJ. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol 2005
  5. doi:10.1016/j.jacc.2005.06.077 PMid:16256877 5. Nieuwlaat R, Capucci A, Lip GY, Olsson SB, Prins MH, Nieman FH, et al. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2006
  6. doi:10.1093/eurheartj/ehl015 PMid:16731536 6. Elezi S, Qerkini G, Bujupi L, Shabani D, Bajraktari G. Management and comorbidities of atrial fibrillation in patients admitted in cardiology service in Kosovo - a single centre study. Anadolu Kardiyol Derg 2010: 10
  7. PMid:20150002 7. Tulner LR, Van Campen JP, Kuper IM, Gijsen GJ, Koks CH, Mac Gillavry MR, et al. Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study. Drugs Aging 2010
  8. doi:10.2165/11319540-000000000-00000 8. Poli D, Antonucci E, Marcucci R, Fatini C, Alterini B, Mannini L, et al. Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score. Thromb Res 2007
  9. doi:10.1016/j.thromres.2007.05.014 PMid:17597186 9. Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007
  10. doi:10.1016/S0140-6736(07)61233-1 10. Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation. Stroke 2008
  11. doi:10.1161/STROKEAHA.107.501825 PMid:18420